Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Sep 12 2017

Emphysema

Snapshot
  • A 23-year-old man presents to the emeCXRrgency department with severe pleuritic chest pain. He tells the resident that he is worried he might have another collapsed lung.
Introduction
  • One of two major presentations of Chronic Obstructive Pulmonary Disease (COPD)
    • including chronic bronchitis and emphysema
  • Characterized by decreased lung function in the setting of air outflow obstruction
  • Defined by alveolar wall destruction and dilation that presents in two forms
    • almost always  due to smoking (even if only secondhand)
    • panlobular is rare and caused by alpha1-antitrypsin deficiency
  • Patients identified as "pink puffers"
    • pink complexion due to hypoxic state, which is less severe than in "blue bloaters"
    • puffer describes compensatory hyperventilation necessary to normalize blood gas
Presentation
  • Symptoms
    • mild dyspnea
    • hyperventilation
    • mild cough
    • pinkish skin coloration
    • fatigue
  • Physical exam
    • late hypercarbia/hypoxia
    • barrel chest (increased AP chest diameter)
    • thin, wasted appearance
    • pursed-lip breathing
    • decreased heart and breath sounds
    • prolonged expiratory phase
    • end-expiratory wheezing
    • scattered rhonchi
    • digital clubbing (only in the presence of other comorbidities such as lung cancer, interstitial lung disease, or bronchiectasis)
Evaluation
  • Diagnosis is based highly on clinical observations
  • ABG
    • hypoxemia
      • decreased PO2
    • acute or chronic respiratory acidosis
      • increased PCO2
  • CXR
    • decreased lung markings with flattened diaphragm
    • hyperinflated lungs with bullae and/or blebs
    • thin-appearing heart and mediastinum
    • barrel-chest
  • PFTs
    • decreased FEV1 / FVC
    • normal or decreased FVC
    • normal or increased TLC (in emphysema and asthma, specifically)
    • decreased DLCO (in emphysema, specifically)
  • Blood cultures
    • order only if patient is febrile
    • Gram stain and sputum culture order in setting of fever or productive cough
Differential
  • Chronic bronchitis, asthma, bronchiectasis
Treatment
  • Medical management
    • O2, beta-agonists, anticholingerics, inhaled/IV steroids, antibiotics
      • indicated for acute exacerbations
        • inhaled Beta-agonists
          • albuterol
        • inhaled anticholinergics
          • ipratropium, tiotropium
        • IV and inhaled steroids
        • broad-spectrum antibiotics
          • use is controversial 
    • smoking cessation, ambulatory O2, bronchodilator, steroids, vaccines indicated for chronic disease
      • smoking cessation
      • ambulatory O2
        • resting PaO2 < 55mmHg or SaO2 <89%
      • bronchodilators
      • systemic or inhaled steroids
      • Pneumococcal and flu vaccines
Prognosis, Prevention, and Complications
  • Prognosis
    • highly dependent of severity of disease, timing and adherence to treatment
    • disease cannot be reversed, only slowed
  • Prevention
    • alpha1-antitrypsin deficiency cannot be prevented, and should be managed accordingly
    • acute exacerbations and progression of disease secondary to smoking can be slowed with lifestyle modifications and strict adherence to treatment measures
  • Complications
    • if untreated or ignored, disease can progress rapidly leading to death
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options